Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Blake

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Immunology|July 18, 2017
Myristoylation: An Important Protein Modification in the Immune ResponseDaniel Ikenna Udenwobele, Ruey-Chyi Su, Sara V Good, et al.
AIDS (London, England)|October 4, 2012
Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohortWilliam J R Turk, Joshua Kimani, Tomasz Bielawny, et al.
AIDS (London, England)|May 16, 2007
Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workersTerry Blake Ball, Hezhao Ji, Joshua Kimani, et al.
Viruses|March 26, 2022
Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex WorkersMarcel Gluchowski, Xiaoqiong Yu, Bernard Abrenica, et al.
Immunology and Cell Biology|May 25, 2011
HIV-specific CD8+ T-cell proliferation is prospectively associated with delayed disease progressionLyle R McKinnon, Rupert Kaul, Joshua Kimani, et al.
Molecular Therapy. Nucleic Acids|October 28, 2015
Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune ActivationRuey-Chyi Su, Andrew Plesniarski, Zhujun Ao, et al.
Vaccine|May 14, 2013
Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sitesMa Luo, Rupert Capina, Christina Daniuk, et al.
Clinical & Translational Immunology|November 12, 2021
Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosisMilla R McLean, Kathleen M Wragg, Ester Lopez, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Immunology|July 18, 2017
Myristoylation: An Important Protein Modification in the Immune ResponseDaniel Ikenna Udenwobele, Ruey-Chyi Su, Sara V Good, et al.
AIDS (London, England)|October 4, 2012
Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohortWilliam J R Turk, Joshua Kimani, Tomasz Bielawny, et al.
AIDS (London, England)|May 16, 2007
Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workersTerry Blake Ball, Hezhao Ji, Joshua Kimani, et al.
Viruses|March 26, 2022
Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex WorkersMarcel Gluchowski, Xiaoqiong Yu, Bernard Abrenica, et al.
Immunology and Cell Biology|May 25, 2011
HIV-specific CD8+ T-cell proliferation is prospectively associated with delayed disease progressionLyle R McKinnon, Rupert Kaul, Joshua Kimani, et al.
Molecular Therapy. Nucleic Acids|October 28, 2015
Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune ActivationRuey-Chyi Su, Andrew Plesniarski, Zhujun Ao, et al.
Vaccine|May 14, 2013
Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sitesMa Luo, Rupert Capina, Christina Daniuk, et al.
Clinical & Translational Immunology|November 12, 2021
Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosisMilla R McLean, Kathleen M Wragg, Ester Lopez, et al.
Pageof 2